Delivery Order SPE2DB24D1021-SPE2DB25FEZHH
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,527.97 to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 mL pens on August 26, 2025, with an ultimate completion date of August 27, 2025. This non-set-aside, firm fixed price delivery order was competitively awarded and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Trulicity is a diabetes medication commonly used in military and veteran healthcare systems as part of comprehensive...
- The Defense Logistics Agency awarded a delivery order valued at $10,343.94 to AmerisourceBergen Drug Corp for the supply of Trulicity 3 mg/0.5 ml pens on August 1, 2025, with an ultimate completion date of August 4, 2025. This firm fixed price delivery order was competitively awarded without set-aside restrictions and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Trulicity is a brand-name diabetes medication widely used in federal healthcare systems, including...
- The Defense Logistics Agency awarded a delivery order valued at $4,340.70 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pens on July 15, 2025, with an ultimate completion date of July 16, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Trulicity is a diabetes management medication commonly used across military and veteran healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $1,166.88 to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 mL pens on August 8, 2025, with completion scheduled for August 11, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Trulicity is a diabetes medication commonly used in military and veteran healthcare systems supported by the Defense...
- The Defense Logistics Agency awarded a delivery order valued at $5,790.66 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 mL pens on September 3, 2025, with completion scheduled for September 4, 2025. This firm fixed-price, competitively awarded delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Trulicity is a brand-name diabetes medication commonly used in federal medical supply chains,...
- The Defense Logistics Agency awarded a delivery order valued at $1,351.35 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pens on June 20, 2025, with completion expected by June 23, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Trulicity is a brand-name diabetes medication commonly used within the military healthcare...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,000.54 for Trulicity 1.5 mg/0.5 ml pens on August 5, 2025, with completion scheduled for August 6, 2025. This firm fixed-price delivery order was competitively awarded without set-aside provisions and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Trulicity is a diabetes medication commonly utilized within military and federal healthcare systems, reflecting...
- The Defense Logistics Agency awarded a delivery order valued at $4,155.60 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens (0.5 mL) with an ultimate completion date of April 23, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under an existing contract vehicle. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Trulicity is a brand-name diabetes medication commonly...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,628.25 to AmerisourceBergen Drug Corp for the supply of Trulicity 3 mg/0.5 ml pens on August 4, 2025. This non-set-aside, firm fixed-price delivery order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 5, 2025. Trulicity is a brand-name diabetes medication commonly used within federal healthcare systems, including military and...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $7,291.68 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens on August 25, 2025, with completion anticipated by August 26, 2025. This firm fixed price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Trulicity is a branded diabetes medication commonly used in military...
- SPE2DB24D1021Indefinite Delivery Contract
- SPE2DB24D1021-SPE2DB25FEZHHDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $6,691.77 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pens on August 5, 2025, with an ultimate completion date of August 6, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Trulicity is a diabetes medication commonly used in military and veteran healthcare systems, reflecting the agency's ongoing pharmaceutical procurement needs for federal medical supply chains. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 and extending through December 2026. This comprehensive pharmaceutical prime vendor contract enables the company to supply a broad range of medications, vaccines, medical devices, and healthcare commodities to support military healthcare programs globally, including the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. AmerisourceBergen Drug Corp's consistent award of non-set-aside, competitively awarded contracts demonstrates its capability to meet federal procurement requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.7k | 8/5/25 |